This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Kg. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Günther Giesler: Innovator in Neurokinin Antagonism
Introduction
Günther Giesler is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that exhibit neurokinin-antagonistic activity. His work is essential for advancing treatments for inflammatory and allergic diseases.
Latest Patents
Giesler holds a patent for "Dipeptides with neurokinin-antagonistic activity." This patent discloses compounds that act as neurokinin (tachykinin) antagonists, which are useful in the treatment or prevention of various inflammatory and allergic conditions. The innovative compounds he has developed represent a significant advancement in therapeutic options.
Career Highlights
Günther Giesler is associated with Boehringer Ingelheim KG, a leading global pharmaceutical company. His work at the company has allowed him to focus on groundbreaking research and development in the field of neurokinin antagonism. His contributions have been instrumental in enhancing the understanding and treatment of related diseases.
Collaborations
Giesler has collaborated with esteemed colleagues such as Franz Esser and Gerd Schnorrenberg. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the pharmaceutical industry.
Conclusion
Günther Giesler's work in neurokinin antagonism has paved the way for new therapeutic approaches to inflammatory and allergic diseases. His contributions to the field are invaluable and continue to influence ongoing research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile